| Authors: |
Kausar F; Leucid Bio Ltd., Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Davis C; Leucid Bio Ltd., Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Larcombe-Young D; Leucid Bio Ltd., Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.; King's College London, CAR Mechanics Group, Department of Precision & Population Oncology, School of Cancer and Pharmaceutical Sciences, London SE1 9RT, UK., Bove C; Leucid Bio Ltd., Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Farzaneh F; King's College London, Department of Haematology, School of Cancer and Pharmaceutical Sciences, London SE5 9RS, UK.; ViroCell Biologics, Zayed Centre for Research into Rare Diseases in Children, London WC1N 1DZ, UK., Graham C; King's College London, Department of Haematology, School of Cancer and Pharmaceutical Sciences, London SE5 9RS, UK.; King's College Hospital, Department of Haematology, London SE5 9RS, UK., Benjamin R; King's College London, Department of Haematology, School of Cancer and Pharmaceutical Sciences, London SE5 9RS, UK.; King's College Hospital, Department of Haematology, London SE5 9RS, UK., Davies DM; Leucid Bio Ltd., Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Maher J; Leucid Bio Ltd., Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.; King's College London, CAR Mechanics Group, Department of Precision & Population Oncology, School of Cancer and Pharmaceutical Sciences, London SE1 9RT, UK.; Department of Immunology, Eastbourne Hospital, Kings Drive, Eastbourne, East Sussex BN21 2UD, UK. |